Zobrazeno 1 - 10
of 487
pro vyhledávání: '"Grzegorz S. Nowakowski"'
Autor:
Matthew E. Stokes, Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew J. Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A. Danziger, Fadi Towfic, Joel Parker, Rebecca L. King, Brian K. Link, Susan L. Slager, Vivekananda Sarangi, Yan W. Asmann, Joseph P. Novak, Akshay Sudhindra, Stephen M. Ansell, Thomas M. Habermann, Patrick R. Hagner, Grzegorz S. Nowakowski, James R. Cerhan, Anne J. Novak, Anita K. Gandhi
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Immunochemotherapy has been the mainstay of treatment for newly diagnosed diffuse large B-cell lymphoma (ndDLBCL) yet is inadequate for many patients. In this work, we perform unsupervised clustering on transcriptomic features from a large c
Externí odkaz:
https://doaj.org/article/4dae5fe5634e4259b6d610f0ad207e8d
Autor:
Suheil Albert Atallah-Yunes, Matthew J. Rees, Thomas E. Witzig, Thomas M. Habermann, Javier Munoz, Madiha Iqbal, Ellen D. McPhail, Grzegorz S. Nowakowski
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Intensified chemoimmunotherapy regimens are often used in young patients with double hit and triple hit lymphoma (DHL/THL) despite no survival benefit compared to R-CHOP. Favorable retrospective reports on the application of CODOX-M/IVAC-R are subjec
Externí odkaz:
https://doaj.org/article/29a18f44c5a4454b8a769df680cc4ff6
Autor:
Allison M. Bock, Jennifer J. Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema K. Tawfiq, Seth Maliske, Matthew J. Maurer, Brian F. Kabat, Jonas Paludo, David J. Inwards, Sabarish Ayyappan, Brian K. Link, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Umar Farooq, Yucai Wang
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Over the last two decades, the frontline therapy for mantle cell lymphoma (MCL) has evolved. However, the impact of subsequent lines of therapy on survival outcomes has not been well characterized. In this study, we investigated the treatmen
Externí odkaz:
https://doaj.org/article/ab1b048610ec4f4e949d375e8ba8630b
Autor:
Aung M. Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J. Inwards, Thomas M. Habermann, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Chimeric antigen receptor T-cell (CAR-T) therapy is the new standard of care in fit patients with refractory or early relapsed diffuse large B-cell lymphoma (DLBCL). However, there may still be a role for salvage chemotherapy (ST) and autologous stem
Externí odkaz:
https://doaj.org/article/46ad365a880749dfb154a7d75af7f42c
Autor:
Cristina Correia, Matthew J. Maurer, Samantha J. McDonough, Paula A. Schneider, Paige E. Ross, Anne J. Novak, Andrew L. Feldman, James R. Cerhan, Susan L. Slager, Thomas E. Witzig, Bruce W. Eckloff, Hu Li, Grzegorz S. Nowakowski, Scott H. Kaufmann
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract How to identify follicular lymphoma (FL) patients with low disease burden but high risk for early progression is unclear. Building on a prior study demonstrating the early transformation of FLs with high variant allele frequency (VAF) BCL2 m
Externí odkaz:
https://doaj.org/article/2262c5bd3f494450bb8803bb96a17ff2
Autor:
Steven Hwang, Jacqueline Wang, Zizhong Tian, Xinyue Qi, Yi Jiang, Shijia Zhang, Richard C. Godby, Sameer Parikh, Wei Ding, Paul Hampel, Javier Munoz, Jonas Paludo, Saad Kenderian, Eli Muchtar, Mazie Tsang, Talal Hilal, Jose Leis, Gita Thanarajasingam, David Inwards, Grzegorz S. Nowakowski, Stephen Ansell, Thomas Habermann, Thomas Witzig, Neil Kay, Shouhao Zhou, Yucai Wang
Publikováno v:
HemaSphere, Vol 7, p e47546cf (2023)
Externí odkaz:
https://doaj.org/article/a53304fbac5b406782ef85c7a2a067cd
Autor:
Allison Bock, Raphael Mwangi, Fatemeh Ataei, Matthew Thorpe, Matthew Maurer, Josh Pritchett, Jacob Shreve, Jonas Paludo, James Cerhan, Arushi Khurana, Thomas Witzig, Thomas Habermann, Yucai Wang, Grzegorz S. Nowakowski, Jason Young
Publikováno v:
HemaSphere, Vol 7, p e6583552 (2023)
Externí odkaz:
https://doaj.org/article/25e8a438e9a74635a82733d488e1570d
Autor:
Aung M. Tun, Yucai Wang, Aasiya Matin, David J. Inwards, Thomas M. Habermann, Ivana Micallef, Patrick B. Johnston, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Han W. Tun, James R. Cerhan, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M. Ansell
Publikováno v:
HemaSphere, Vol 7, Iss 4, p e869 (2023)
Immune checkpoint inhibitors (ICIs) and brentuximab vedotin (BV) are novel agents for classic Hodgkin lymphoma, including relapse after autologous stem cell transplant (ASCT). However, their impact on survival post-ASCT relapse, in comparison with co
Externí odkaz:
https://doaj.org/article/a4ab29ec31e74a8da4ff4f0b41f86131
Autor:
Sanjal H. Desai, Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew Feldman, David J. Inwards, Ivana Micallef, Patrick Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-6 (2022)
Abstract Studies evaluating Positron Emission Tomography scan after 2 cycles of chemotherapy (PET2) in newly diagnosed diffuse large B cell lymphoma (DLBCL) are heterogeneous in patient characteristics, treatments and have conflicting results. Here w
Externí odkaz:
https://doaj.org/article/78c8b113aa5c400095ef1c63894b6828
Autor:
Yucai Wang, Shouhao Zhou, Xinyue Qi, Fang Yang, Matthew J. Maurer, Thomas M. Habermann, Thomas E. Witzig, Michael L. Wang, Grzegorz S. Nowakowski
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Front-line treatment for follicular lymphoma has evolved with the introduction of maintenance therapy, bendamustine (Benda), obinutuzumab (G), and lenalidomide (Len). We conducted a random-effects Bayesian network meta-analysis (NMA) of phas
Externí odkaz:
https://doaj.org/article/51f844b659894e18bc8376532b1a56f9